Latest news
KPTI Maintained by Piper Sandler -- Price Target Lowered to $7.0 - GuruFocusGuruFocus · Fri, 31 Jul 2026 07:00:00 GMTKPTI Looks 18.2% Overvalued on GF Value™ Amid Mixed Clinical Tri - GuruFocusGuruFocus · Fri, 31 Jul 2026 06:58:07 GMTKaryopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - KaryopharmKaryopharm · Thu, 30 Jul 2026 07:00:00 GMT